Finance

Lists
LTGO:NASDAQ
Latigo Biotherapeutics, Inc.
$22.80
-3.92%
(-0.93) 1D
Sep 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LTGO...
Open
$23.72
High
$23.98
Low
$22.44
Avg. vol.
272.24K
Volume
0.00
52-wk high
$25.90
52-wk low
$17.22
No. of employees
59
Open
$23.72
High
$23.98
Low
$22.44
Avg. vol.
272.24K
Volume
0.00
52-wk high
$25.90
52-wk low
$17.22
No. of employees
59
News stories
From web sources and news partners
About Latigo Biotherapeutics, Inc.
CEO-
Employees59
Founded2018
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to LTGO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for LTGO in the last 3 months.
Highest
Current $22.80
$73.00 (+220.18%)
Average
$57.67 (+152.94%)
Lowest
$50.00 (+119.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yatin Suneja
Guggenheim
Buy
Initiated
$50.00
+119.3%
09/01/2026
Akash Tewari
Jefferies
Buy
Initiated
$50.00
+119.3%
09/01/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
$73.00
+220.2%
09/03/2026
Awaiting results...
Call Time: Thu, Sep 3, 4:00 PM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -$0.81
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
18.69M
17.63M
Total research and development expenses
-
-
Selling, general, and admin expenses
2.82M
5.80M
Operating expense
21.51M
23.44M
Total operating expenses
21.51M
23.44M
Operating income
-21.51M
-23.44M
Other non operating income
43.00K
1.00K
EBT including unusual items
-20.95M
-22.96M
EBT excluding unusual items
-20.95M
-22.96M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-20.95M
-22.96M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
517.00K
474.00K
Interest expense
-
-
Net interest expenses
517.00K
474.00K
Depreciation and amortization charges
-
-
EBITDA
-21.44M
-23.39M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps